Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors
Clinical trial NCT04309968 · UNKNOWN
Trial details
- NCT number
- NCT04309968
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2022-12-31
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.